Source: International Congress 2016 – Late-breaking topics in airways disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jan Stolk (Leiden, Netherlands), M. Fumagalli, Jan Stolk, C. Ciaramelli, R. Bussei, V. Mazzoni, S. Viglio, Paolo Iadarola, C. Airoldi. LATE-BREAKING ABSTRACT: Exploiting the ability of 1H-NMR to differentiate patients with severe alpha-1-antitrypsin deficiency from controls based on metabolome profiling of exhaled breath condensate. Eur Respir J 2016; 48: Suppl. 60, 1971

Member's Comments

No comment yet.

Related content which might interest you: Influence of inflammatory phenotype in severe refractory asthma on metabolomic profile of oxidative stress in exhaled breath condensate (EBC) Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Unbiased clustering of severe asthma patients based on exhaled breath profiles Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Phenotyping of COPD by integrated metabolomic profiling of exhaled breath condensate and peripheral blood Source: International Congress 2015 – Monitoring and phenotyping COPD Year: 2015 The impact of acute smoke exposure on selected biomarkers in exhaled breath condensate in COPD patients and healthy smokers Source: International Congress 2016 – Molecular pathways of smoking-induced diseases Year: 2016 Analysis of exhaled air for a rapid, sensible and specific diagnosis of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD Source: Eur Respir J 2011; 38: 1301-1309 Year: 2011 Decreased levels of bis-S-bimane in exhaled breath condensate of COPD Source: International Congress 2015 – Exhaled biomarkers in children and adults with airways disease Year: 2015 Diagnosis of lung diseases based on proteomic analysis of exhaled breath condensate Source: International Congress 2017 – Clinical problems in lung diseases Year: 2017 Identification of MDA associated clusters in exhaled breath samples of patient measurements from GC-IMS spectra Source: International Congress 2015 – Multidimensional analysis of respiratory problems Year: 2015 Lung disease diagnostic method based on proteomic analysis of exhaled breath condensate Source: International Congress 2019 – Basic research of airway diseases Year: 2019 Periostin in exhaled breath condensate as a biomarker of different severe asthma phenotypes. Source: International Congress 2017 – Systemic and airway biomarkers Year: 2017 Exhaled breath condensate sample collection: standards and open issues Source: Eur Respir Monogr 2010; 49: 152-161 Year: 2010 Better characterization of local inflammation in COPD: detection of new biomarkers in exhaled breath condensate Source: Eur Respir J 2006; 28: Suppl. 50, 747s Year: 2006 Distinct arginine and tryptophan metabolism in mild and severe asthma as compared to controls based upon analyses of exhaled breath condensate Source: Annual Congress 2010 - Exhaled biomarkers: smells like disease Year: 2010 Exhaled breath condensate biomarkers in COPD Source: Eur Respir J 2008; 32: 472-486 Year: 2008 Differential diagnosis between newly diagnosed asthma and COPD using exhaled breath condensate metabolomics: a pilot study Source: Eur Respir J, 51 (3) 1701825; 10.1183/13993003.01825-2017 Year: 2018 Metabolomic analysis of exhaled breath condensate in patients with asthma and COPD Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 NMR-based metabolomics of exhaled breath condensate for assessing the effects of inhaled corticosteroids in COPD patients Source: International Congress 2017 – Management of COPD Year: 2017 Measuring exhaled NO and breath condensate: where do we stand? Source: Annual Congress 2006 - PG14 - Noninvasive monitoring of asthma inflammation and treatment Year: 2006 Adaptation of differential ion mobility spectrometry (DMS) for discrimination of specific biomarkers in exhaled breath in patients with severe renal-pulmonary dysfunction Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011